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Transintaral Heterogeneity of Nore
Human Hearts
SCOTT L . BEAU, MD, JEFFREY E . SAFFITrZ, MD, PH
Saint Louis, Missouri
Objectives. The aim of this study was to determine whether
regional heterogeneity in myocardial sympathetic neural function
measured by the uptake of norepinephrine could account for the
spatial heterogeneity of beta-adrenergic receptor down-regulation
that occurs in the failing human heart .
Background. Myocardial beta-adrenergic receptor density and
function are diminished in patients with chronic heart failure .
Down-regulation occurs predominantly in the subendocardium,
suggesting that local rather than systemic alterations in sympa-
thetic neural function may be responsible. Although some studies
have implicated hypefunction of cardiac sympathetic nerves with
defective norepinephrine uptake, others suggest increased cardiac
sympathetic nerve activity with unimpaired uptake .
Methods. We measured norepinephrine uptake by incubating
transmural slices of the left ventricle from 19 patients who had
chronic heart failure and three nonfailing control hearts with
[3H]norepinephrine with or without desipramine, a neuronal
uptake blocker. The density of uptake sites was measured in
subepicardial and subendocardial myocyte regions with light
microscopic autoradiography .
Results. Although the amount of [ -%norepinephrine uptake
Myocardial beta-adrenergic receptor density and function
are diminished in patients with chronic congestive heart
failure (1-4) . Several lines of evidence suggest that local
rather than systemic factors may be primarily responsible in
mediating beta-receptor down-regulation in the failing heart
(4-6) . For example, decreased beta-adrenergic receptor
density and adrenergic neurotransmitter depletion have been
observed in the failing right ventricle but not in the normal
left ventricle of patients with primary pulmonary hyperten-
sion (6) . Because beta-adrenergic receptors are known to be
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varied considerably i
n
failing ventricles, uptake was directly
proportional (r = 0.46, p < 0 .05) to beta I -adrenergic receptor
density measured in additional slices with radioligand binding
assays . In addition, marked hansmural heterogeneity in I ,%
norepinephrine uptake was consistently observed in failing
ventricles . Uptake in subendocardial myocyte regions was sig-
nificantly less than in subepicardial regions (mean I±SDJ
subepicardial/subendocardial uptake ratio 4 .7 ± 4.8, p < 0.01).
The extent of transmural heterogeneity in norepinephrine uptake
was similar in patients with idiopathic and ischemic cardlo-
tnyopathy. In contrast, nonfailing hearts exhibited more uni-
form transmural ['H]norepinephrine uptake (subepicardial/
subendocardial uptake ratio 1 .8 ± 1 .2, p = NS) .
Conclusions . Specific [3H]norepinephrine accumulation is ap-
proximately fivefold lower in subendocardial regions of failing left
ventricles than in subepicardial regions . These findings support
the hypothesis that a subendocardial defect in norepinephrine
uptake may chronically elevate local interstitial catecholamine
levels and thereby down-regulate beta-adrenergic receptors in a
spatially heterogeneous distribution .
(J Am Coll Cordial 1994,23 .-579-85)
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down-regulated in response to prolonged agonist exposure
(7,8), elevations in local catecholamine concentration are
likely to be critical determinants of beta-adrenergic receptor
density and function in the failing heart .
Local myocardial neurotransmitter concentration is de-
termined by several factors, one of the most important being
uptake of norepinephrine into presynaptic nerve terminals
by the neuronal uptake mechanism (9,10) . To elucidate
potential mechanisms that might mediate down-regulation of
myocardial beta-adrenergic receptors, several investigators
have studied norepinephrine kinetics in patients with heart
failure, but the results have been inconsistent . Swedberg et
al . (11,12) reported an increased aortocoronary sinus norepi-
nephrine gradient in patients with congestive heart failure .
Some (13-15) have concluded that the cause of increased
spillover of norepinephrine from the heart in patients with
congestive failure is increased sympathetic neural discharge,
whereas others (16,17) have reported a defect in cate-
cholatnine uptake .
In a previous autoradiographic study of the distribution of
beta-adrenergic receptors in the failing human heart, we (4)
observed that beta-receptor down-regulation occurs in a
0735-1097/94/$7 .00
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transmurally heterogeneous fashion and is attributable pri-
marily to a selective reduction of beta-receptors in the
subendocardium . This observation suggests that if local
derangements in catecholamine function mediate myocardial
beta-adrenergic receptor down-regulation, then such de-
rangements may be heterogeneously distributed . Accord-
ingly, we developed an autoradiographic method to charac-
terize the transmural distribution of norepinephrine uptake
in left ventricular slices of failing human hearts . With this
approach, we sought to determine whether potential regional
alterations in catecholanine uptake might account for the
marked spatial heterogeneity of beta-receptor down-
regulation .
Methods
Tissue procurement . Because of the limited availability of
fresh, viable human myocardium, preliminary experiments
designed to characterize [ 3H]norepinephrine uptake condi-
tions were performed using normal canine left ventricular
myocardium. Subsequent norepinephrine uptake studies
were performed using freshly excised hearts obtained from
I I patients with idiopathic dilated cardiomyopathy and 8
patients with ischemic cardiomyopathy who were undergo-
ing heart transplantation at Barnes Hospital between March
1991 and October 1992 . Selected clinical features of these
transplant recipients are shown in Table 1 . Eight patients
were being treated with intravenous catecholamine therapy
at the time of heart transplantation and all patients were
taking other medications including diuretic drugs, digoxin
and afterload reducers (including angiotensin-converting
enzyme inhibitors) .
Freshly excised, transmural samples of left ventricular
myocardium were also obtained from three nonfailing con-
trol hearts . These samples came from three hearts not used
for transplantation, two from vital organ donors and one
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from a valve homograft donor . The donors included two
motor vehicle accident victims (a 38-year old man and a
3-year old boy) with massive closed head injury and a
43-year old woman with brainstem herniation after a cere-
brovascular accident . All three subjects had been treated
with inotropic medication within 24 h of tissue harvest, but
none had a clinical history of congestive heart failure .
Informed consent for research use of human tissue was
obtained in all cases. The study protocol was approved by
the Washington University Human Studies Committee on
October 28, 1990. Protocols involving animal tissue were
approved by the Washington University Animal Studies
Committee on November 26, 1990 .
[ 3H]Norepinephrine uptake activity. Uptake of [ 3H]nor-
epinephrine in myocardial slices was assessed using proce-
dures similar to those described by Sharma and Banerjee
(18) and Liang et al . (5) . Thin (-0.5 mm), transmural slices
of fresh left ventricular myocardium were prepared with a
Stadie-Riggs microtome (Thomas Scientific) and stored
briefly in cold, oxygenated, modified Krebs solution (con-
taining in mmol/liter: sodium chloride 118, potassium chlo-
ride 4.7, calcium chloride 2.5, magnesium chloride 0 .54,
sodium bicarbonate 25, sodium phosphate (monobasic) 1,
and dextrose 11, as well as 200 mg/liter of ascorbic acid,
20 mg/liter of EDTA and 20 mg/liter of pargyline) . Total
['H]norepinephrine uptake was measured in triplicate slices
incubated at 37°C in modified Krebs solution containing
25 nmollliter of D.L-[7-3H(N)]norepinephrine hydrochloride
(8 to 15 Ci/mmol . New England Nuclear) in the presence or
absence of 0.3 limolAher of desipramine, a specific inhibitor
of uptake function . In preliminary studies using canine
myocardium, nonspecific uptake was also measured by
incubating tissue slices with
[3
H]norepinephrine (without
desipramine) at 4°C . After incubation, tissue slices were
rinsed three times in ice-cold modified Krebs solution in the
absence
of [3
H]norepinephrine or desipramine and blotted
on filter paper. To determine total specific [ 3H]norepineph-
rine uptake per mg dry tissue weight, some slices incubated
with ['H]norepinephrine with and without desipramine were
desiccated overnight in an oven at 50°C, weighed, solubi-
lized with 0.5 ml of Solvable (NEN DuPont) and radioactiv-
ity measured with liquid scintillation spectrometry . Prelimi-
nary experiments in multiple transmural slices of left
ventricle obtained from five canine hearts and analyzed in
five separate preparations indicated that specific uptake was
linear between 5 and 30 min of incubation and represented
-75% of the total uptake whether nonspecific binding was
assessed at 4°C or in the presence of desipramine . In
subsequent experiments using human tissue, desipramine
was used to assess nonspecific binding .
Radioligand binding assays . The total content of beta-
adrenergic receptors in transmural sections of left ventricu-
lar myocardium was determined by Scatchard analysis of
binding isotherms, as previously reported (19) . Briefly,
transmural frozen sections of unfixed tissue, 12 lAm thick-
ness, were incubated under steady state conditions with
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'table 1. Clinical Characteristics of Heart Transplant Recipients
Age (y)
45 .3 ± 3 .1
Race
White 16
Black 3
Gender
wale 17
Female 2
Duration of symptoms (mo)
32 .7 ± 8.5
New York Heart Association functional class
2
III 6
IV
Hemodynamic index
Cardiac output (liters/min) 4.93 ± 0.35
Cardiac index (liters/min per m2) 2.51 0.16
Left ventricular ejection fraction (%) 22 .2 IS
Pulmonary capillary wedge pressure (mm Hg) 19 .7 1 .8
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selected concentrations (1 .1 to 107 pmol/liter) of (-)[ 1 '- 5 1]
iodocyanopindolol (1,900 to 2,200 uCi/mmol ; New England
Nuclear) in the presence or absence of 10' mol/liter of
L-propranolol. After rinsing to remove nonspecifically bound
ligand, sections were transferred to tubes and radioactivity
was quantified with gamma scintillation spectrometry .
The relative proportions of beta,- and beta
2
-adrenergic
receptors in transmural sections of left ventricular myocar-
dium of control and failing hearts were determined by
incubating tissue sections with 25 pmol/liter iodocyanopin-
dolol in the imesencee or absence of 10 -7 molhiter CGP-
20712A, a highly beta,-selective antagonist. We (19) have
previously shown that under these conditions, binding of
iodocyanopindolol to beta,-sites is inhibited by -95%,
whereas binding to beta,-sites is inhibited by only -1% .
Beta, -adrenergic receptor density values in transmural sec-
tions were calculated by multiplying the total beta-receptor
density, determined with binding isotherms, by the propor-
tion of the beta, subtype, determined in sections incubated
with radioligand and CG020712A . The values were cor-
rected to account for the 5% iodocyanopindolol binding to
beta, sites and the 1% inhibition of iodocyanopindolol bind-
ing to beta2 sites .
Autoradiography . The distribution and amount of
[3
H]norepinephrine uptake in transmural sections of failing
and control ventricles were determined with quantitative
light microscopic autoradiography . Myocardial slices incu-
bated with [3Hjnorepinephrine with or without desipramine
were frozen and transmural sections 12-Am thick were cut
with a cryostat microtome, mounted on gelatin-coated slides
and air dried . Gelatin-coated coverslips were coated with
Kodak NTB2 nuclear track emulsion (Eastman Kodak),
dried at room temperature for L-3 h and glued at one end to
the slides containing the radiolabeled myocardial sections .
The preparations were stored in light-tight boxes at 4°C for
approximately 6 weeks, after which the unglued edge of each
coverslip was gently lifted from the slides and the emulsion
was developed with Kodak D19 developer (diluted 1 :1 with
water) for 3 min and fixed with Kodak fixer for I min at 25°C .
Tissue sections were then stained with hematoxylin-eosin
and the coverslips were sealed permanently to the slides .
The tissue and overlying autoradiographic grains in the
emulsion layer were examined by light microscopy and
photographed and grain densities determined by counting
grains per unit area of subepicardium and subendocardium
(defined as tissue regions included within five high power
fields of the epicardial and endocardial surfaces, respec-
tively, at a magnification of x630) . Data from individual
sections were calculated as mean values of grain density
measurements from >_10 distinct microscopic fields . Com-
posite data points were determined from the average of at
least three separate sections per patient .
[ 3
H]Norepinephrine release experiments
. Additional tis-
sue slices from three failing hearts were incubated at 37°C
for 15 min in oxygenated, modified Krebs solution contain-
ing 25 nmol/liter
of (3
HInorepinephrine with or without
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0.3 jumol/liter of desipramine . After three rinses in ice-cold
modified Krebs solution, the tissue slices were blotted onn
filter paper. Each slice was cut into three approximately
equal portions, yielding subendocardial, midmyocardial and
subepicardial samples . The subepicardial and subendocar-
dial samples were placed in separate vials containing 8 ml of
fresh, oxygenated modified Krebs solution and, after incu-
bation at 37°C for 10 min, 80 gi of
10-2
mol/liter tyramine
was added to yield a final tyramine concentration of 10'
mol/liter, The amount of tyramine-induced
[3
H]norepineph-
rine release was measured with liquid scintillation spectrom-
etry in 80-10 aliquots removed at selected intervals over the
ensuing 15 min . Background release of [3Hjnorepinephrine
was determined by simultaneously incubating additional
epicardial and endocardial samples without tyramine .
High performance liquid chromatographic analysis of tis-
sue radioactivity. The chemical composition of tissue radio-
activity after selected intervals of [3H]norepinephrine uptake
or release was analyzed with liquid chromatography, using a
sensitive electrochemical detection method as previously
described (20) .
Data analysis, Results are expressed as mean value ±
SD. Statistical analyses were performed on a Macintosh l1ci
computer using the Stat View 4.0 application package .
Differences in total [ 3Hjnorepinephrine uptake between
groups were analyzed using one-way analysis of variance
(ANOVA) with the Scheffd test . Analysis of the difference in
subepicardial and subendocardial uptake and release within
individual groups was performed using the difference
method and testing the significance of the differences be-
tween the mean subendocardial and mean subepicardial
uptake or release . The relation between [ 3Hjnorepinephrine
uptake and beta,-receptor density was analyzed using the
Fisher r to z transformation of the correlation . Significance
was defined as p < 0.05 .
Results
Total
[3
H]norepinephrine uptake in control and failing
human myocardium . When group data were compared, no
significant difference was observed in the mean total specific
uptake in slices of failing and control left ventricles (specific
[3Hjnorepinephrine uptake 110 .2 ± 17.0 fmol/mg dry tis-
sue weight in nonfailing control ventricles vs . 97.2 ±
50.6 fmol/mg dry tissue weight in failing hearts) nor was a
difference in uptake observed between control ventricles and
subsets of failing ventricles categorized on the basis of
etiology (Fig . 1) . Specific [ 3
Hjnorepinephrine uptake in
patients receiving intravenous dobutamine therapy before
heart transplantation was not significantly different from that
observed in hearts of patients not treated with dobutamine .
The amount of total specific
[3
H]norepinephrine uptake
varied considerably among samples of failing left ventricular
myocardium, with values ranging from 3 .8 to 193.2 fmol/mg
dry tissue weight. However, as shown in Figure 2, the total
amount of specific
[3
HInorepinephrine uptake was directly
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Flpre 1 . Specific [ 3 fflnorepinephrine ([3H]NE) uptake in control
and failing human left ventricular myocardium . Triplicate transmu-
rat slices of each ventricle were incub,,teJ with 25 nmol/liter of
(IHInorepinephrine in the presence or absence of 0 .3 pmoUliter of
desipramine for 15 min . Specific uptake was calculated by subtract-
ing nonspecific from total uptake in each slice . Grouped data are
expressed as mean value ± SD for control nonfailing (NF, n = 3),
failing (F. n = 19), idiopathic cardiomyopathy (IDC, n = 11)
ischemic cardiomyopathy (ISC, n = 8). dobutamine-treated
(+ DOBUT, n - 8) and dobutamine-untreated (- DOBUT, n = 11)
hearts .
proportional to the beta 1 -adrenergic receptor content of the
tissue, determined in separate transmural slices with radio-
ligand binding assays (r = 0 .46, p < 0.05) .
Tromural dWbution of PHInorepinephrine uptake in
falling and control left ventricles . Technically acceptable
autoradiographic preparations were available for analysis in
all 3 nonfailing control and It failing left ventricles . Figure 3
shows representative autoradiographs prepared from the
YweL Relation between specific Ninorepinephrine WHINE)
uptake and beta,-adrenergic receptor density in transmurai slices of
failing left ventricles .
100
200
SPECIFIC [3H]NE UPTAKE
(frral/nig dry weight)
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heart of a patient with idiopathic dilated cardiomyopathy . It
demonstrates that the amount of specific I'Hlnorepinephrine
uptake was considerably less in regions of closely packed
myocytes in the subendocardium than in myocyte regions of
the subepicardium . Figure 4 summarizes the autoradio-
graphic measurements obtained in the subepicardial and
subendocardial myocyte regions of the 3 nonfailing control
and 16 failing left ventricles . Marked transmural heteroge-
neity in
13
Hlnorepinephrine uptake was seen in the failing
ventricles . Specific [3H]norepinephrine uptake was signifi-
cantly lower in subendocardial myocvte regions than in
subepicardial myocyte regions in the heart failure group
(subepicardial :subendocardial uptake ratio 4 .7 ± 4 .8, p <
0.01). The magnitude of the subepicardial/subendocardial
uptake ratio was similar in both the idiopathic dilated (4 .6 ±
4.5) and ischemic (5 .0 ± 5.3) cardiomyopathy subgroups. In
contrast, the transmural distribution of specific uptake in the
nonfailing control hearts was substantially more uniform .
There was no significant difference between the amount of
subepicardial and subendocardial uptake in these hearts.
Spontaneous and tyrandwinduced release of [3H]norepi.
nephrine In failing myocardium. To determine whether the
differences in amounts of subepicardial and subendocardial
radioactivity measured after a 15-min incubation interval
could be due to regional differences in [ 3H]norepinephrine
release, we measured spontaneous and tyramine-induced
['Hlnorepinephrine release in subepicardial and subendocar-
dial samples prepared from three failing human left ventri-
cles. Figure 5 shows the amount
of [3
H]norepinephrine
released from subepicardial and subendocardial samples
incubated in the presence or absence of tyramine . No
significant regional differences were observed in the amount
of (3111norepinephrine released spontaneously (without tyra-
mine) or in response to tyramine after 15 min of incubation .
FlIgh performance liquid chromatographic determination
of norepinephrine metabolicah To determine whether
[3
HInorepinephrine was being metabolized under the exper-
imental conditions employed, the chemical composition of
tissue radioactivity in three hearts was analyzed with high
performance liquid chromatography. After incubation of
slices with
[3
H]norepinephrine for 15 min, norepinephrine
was extracted from tissue and processed for analysis with
high performance liquid chromatography . Eluant was col-
lected in 1-min fractions, and radioactivity in each fraction
measured by liquid scintillation spectrometry was compared
with total radioactivity measured in an aliquot of sample not
subjected to high performance liquid chromatography. Ap-
proximately 90% of tissue radioactivity that had accumu-
lated after 15 min of incubation eluted in a single fraction
with a retention time (3 to 4 min) characteristic of unmetab-
olized norepinephrine . Similar results (91% elution in nor-
epinephrine fraction) were obtained for tissue slices from
tyramine release experiments that had been incubated at
3'7*C in oxygenated buffer for 45 min .
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Figure 3 . Representative autoradiographs showing
relative grain densities in myocyte regions of failing
human left ventricular slices incubated with 25 nmoll
liter of ['H]norepinephrine in the absence (left pan-
els) or presence (right panels) of 0 .3 pmol/liter of
desipramine . Top, Subepicardial myocyte regions .
Bottom, Subendocardial myocyte regions . Magnifi-
cation is the same in all panels . Original magnifica-
tion x400 (bar = 25 pm) .
Discussion
Patients with chronic congestive heart failure are known
to have depleted cardiac norepinephrine stores (21,22) de-
Figure 4 . Ratios of relative specific grain densities in subepicardial
and subendocardial myocyte regions in control and failing ventri-
cles . At least 10 grain density measurements were made in each
location in triplicate samples from each ventricle . Grouped data are
expressed as mean value ± SD for the ratio of subepicardial/
subendocardial ['H]norepinephrine ([3H]NE) uptake in control non'
failing (NF, n = 3), failing (F, n = 16), idiopathic cardiomyopathy
(IDC, n = 9), ischemic cardiomyopathy (ISC, n = 7), dobutamine-
treated (+ DOBUT, n = 7) and dobutamine-untreated (-DOBUT, n
= 9) hearts *p < 0.01 . tp < 0.05 .
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spite increased circulating catecholamine levels (23-26) .
Furthermore, myocardial interstitial concentrations of nor-
epinephrine appear to be increased in patients with heart
failure (12,16). The normal heart extracts a large percent of
perfused norepinephrine by uptake into sympathetic nerve
terminals (9,10), and abnormalities in this uptake mechanism
in patients with chronic heart failure have been implicated as
a major cause of alterations in cardiac norepinephrine pro-
cessing (16,17) . However, some investigators (13-15) have
suggested that a primary increase in cardiac sympathetic
nerve activity is the underlying defect that promotes de-
rangements in cardiac norepinephrine spillover in patients
with heart failure .
[3
H]Norepinephrine uptake and beta,-2drenergic receptor
density. In the present study, the amount of specific
['H]norepinephrine uptake was highly variable among slices
prepared from nonfailing control hearts and failing hearts .
The total amount of radioactivity measured in vitro after
incubation of tissue slices in a solution containing [3H]nor-
epinephrine depends on many variables, including relative
rates of uptake and release, the sizes and metabolic turnover
rates of endogenous norepinephrine pools and, probably
most important, the relative distribution of large nerves and
richly innervated vessels within individual tissue slices .
Despite these technical limitations, we did observe a direct
relation between the amount of total specific
[3
H]norepi-
nephrine accumulation and total tissue beta, -adrenergic : re-
ceptor density in slices of failing myocardium . The greatest
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SPONTANEOUS TYRAMINE-INDUCED
Figure 5
. Spontaneous and tyramine-induced ['H]norepinephrine
([SHINE) release in failing ventricles (n = 3)
. Triplicate slices of
myocardium were incubated for 15 min with 25 nmolNer of
['H]norepinephrinc . Subepicardial (hatched bars) and subendocar-
dial (WM bars)
regions were then transferred to fresh buffer and
incubated with or without 10' mol1liter of tyramine for an addi-
tional 15 min to promote release . Grouped data are expressed as
mean value ± SD for [3H]norepinephrine release as a percent of
total ['H]norepinephrine accumulation . (Total ['Hlnorepinephrine
accumulation was calculated by adding the total amount of
['H]norepinephrine released to the amount of ['H]norepinephrine
remaining in the tissue at the end of the release interval .)
amount of receptor down-regulation (ttiat is, the lowest
beta,-receptor density) was associated with the lowest accu-
mulation
of [3
H]norepinephrine . Statistical analysis indi-
cated that only -21% of the variance in the beta-receptor
data could be attributed to differences in ['H]norepinephrine
uptake. However, because of the difficulties involved in
comparing the total amount of ['HJnorepinephrine accumu-
lation in whole slices of control and failing hearts, we
devised a novel autoradiographic method to compare re-
gional accumulation
of [3
H]norepinephrine within regions of
compact myocytes in transmural left ventricular slices .
Autoradiographic delineation of regional PHInorepineph-
rine uptake. Specific uptake
of [3
H]norepinephrine was
measured autoradiographically under conditions in which
tracer uptake was linear, inhibitable by desipramine and not
subject to significant net catabolism. This approach was
'cased on our previous observations (4) that beta-adrenergic
receptors are down-regulated in the failing heart in a spa-
tially heterogeneous fashion, such that the degree of down-
regulation is significantly more extensive in subendocardial
than in subepicardial regions
. Our observations in the
present study indicate that specific ['H]norepinephrine ac-
cumulation was fivefold lower in subendocardial myocyte
regions of failing left ventricles than in subepicardial myo-
cyte regions .
Although the transmural distribution of specific [ 3H]nor-
epinephrine uptake was more uniform in the nonfailing
control hearts, the number of control hearts was small
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because of unavoidable limitations in the availability of
viable, fresh, normal human myocardium . However, the
more uniform transmural pattern of norepinephrine uptake is
consistent with the distribution of beta-receptors in normal
myocardium, which is also uniform (4,27) .
Limitations of the study . Potential confounding variables
in our study include treatment of patients with heart failure
with intravenous dobutamine and digoxin, medications
known to interact with components of the adrenergic ner-
vous system. However, no differences in total or regional
accumulation
of [3
H]norepinephrine uptake were detected in
patients with heart failure who were and were not treated
with intravenous catecholamines before heart transplanta-
tion . Furthermore, all control hearts had also been exposed
to intravenous catecholamines within 24 h of tissue harvest .
In addition, although patients with heart failure had been
receiving treatment with digoxin, digitalis glycosides have
been shown to only weakly inhibit neuronal uptake of
[ 3H]norepinephrine in vitro in human atrial muscle at con-
centrations far exceeding therapeutic levels (28) . Tissue
edema and fibrosis might retard in vitro [ 3H]norepinephrine
uptake in myocardial tissue slices from patients with conges-
tive heart failure. However, we selected regions free of
grossly visible fibrosis for determination of uptake capacity,
and grain density measurements were performed in micro-
scopic fields composed of closely packed myocytes that
appeared to be uninvolved by edema or fibrosis . Barber et al .
(29) have shown that viable regions apical to myocardial
infarcts may be denervated . Regional sympathetic denerva-
tion may be an important determinant of spatial heterogene-
ity in norepinephrine uptake activity in hearts of patients
with ischemic cardiomyopathy . However, in the present
studies, tissues were sampled from regions distant from
areas of scarring and not located apical to healed infarcts .
Thus, the effects of regional sympathetic denervation on
heterogeneity in norepinephrine uptake in ischemic cardio-
myopathy samples was probably limited .
Our results do not indicate whether a potential subendo-
cardial defect in norepinephrine uptake in heart failure
precedes and promotes desensitization and down-regulation
of myocardial beta-receptors . Perhaps factors promoting
myocardial overload states or direct myocyte injury are
responsible for both the decrease in neuronal uptake of
norepinephrine and the diminution of beta-receptor density
and responsiveness . Recent advances in the noninvasive
assessment of myocardial adrenergic function, using [1231
] _
meta-iodobenzylguanidine scintigraphy to evaluate uptake- I
function (30) and positron emission tomography to measure
myocardial beta-adrenergic receptor density (31), may even-
tually help resolve this question. The mechanism underlying
the observed reduction in subendocardial norepinephrine
uptake activity has not been addressed in these experiments .
Further studies to evaluate the distribution of sympathetic
nerve terminal density and specific neuronal uptake binding
sites seem warranted .
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Clinical implications. Our results may have implications
regarding the pathogenesis of malignant ventricular tachy-
arrhythmias in patients with heart failure . Regional hetero-
geneity of electrophysiologic function has been well docu-
mented in models of heart failure (32,33). The transmural
gradient in norepinephrine uptake function characterized in
our study may potentiate and amplify such electrical hetero-
geneity, thus increasing the likelihood of developing reen-
trant circuits . Locally elevated levels of interstitial cate-
cholamines may also potentiate triggered activity, especially
in light of evidence that catecholamines result in increased
delayed afterdepolarizations in certain preparations (34) .
Evaluation of failing hearts with multichannel electrophysi-
ologic mapping devices might further elucidate these poten-
tial consequences of spatially heterogeneously altered sym-
pathetic activity .
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